INS and type 2 diabetes mellitus: Intensive insulin therapy is recommended for newly diagnosed T2DM patients exhibiting elevated HbA1c levels ≥9.0%, fasting plasma glucose (FPG) ≥11.1 mmol/L, or pronounced hyperglycemic symptoms.